AU2010212348B2 — Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
Assigned to Avanir Pharmaceuticals Inc · Expires 2013-05-09 · 13y expired
What this patent protects
P.OPEIDDMRSpcc M529M3c18/0I&200 Phamiaceutical compositions and methods for treating neurological disorders by adlminitering same are provided. The compositions comprise dextromethorphan in combination with quinidine. WO 2004/006930 PCT/US2003/022303 Figu 7. .Mean Pain Rating…
USPTO Abstract
P.OPEIDDMRSpcc M529M3c18/0I&200 Phamiaceutical compositions and methods for treating neurological disorders by adlminitering same are provided. The compositions comprise dextromethorphan in combination with quinidine. WO 2004/006930 PCT/US2003/022303 Figu 7. .Mean Pain Rating Fittd vaues SUBSTITUTE SHEET (RULE 26)
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.